275 related articles for article (PubMed ID: 22872109)
1. Do we know enough about the immune pathogenesis of acute coronary syndromes to improve clinical practice?
Matusik P; Guzik B; Weber C; Guzik TJ
Thromb Haemost; 2012 Sep; 108(3):443-56. PubMed ID: 22872109
[TBL] [Abstract][Full Text] [Related]
2. Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease.
Moreira DM; da Silva RL; Vieira JL; Fattah T; Lueneberg ME; Gottschall CA
Am J Cardiovasc Drugs; 2015 Feb; 15(1):1-11. PubMed ID: 25369900
[TBL] [Abstract][Full Text] [Related]
3. Update on acute coronary syndromes: the pathologists' view.
Falk E; Nakano M; Bentzon JF; Finn AV; Virmani R
Eur Heart J; 2013 Mar; 34(10):719-28. PubMed ID: 23242196
[TBL] [Abstract][Full Text] [Related]
4. Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy.
McLaren JE; Michael DR; Ashlin TG; Ramji DP
Prog Lipid Res; 2011 Oct; 50(4):331-47. PubMed ID: 21601592
[TBL] [Abstract][Full Text] [Related]
5. Stabilisation of atherosclerotic plaques. Position paper of the European Society of Cardiology (ESC) Working Group on atherosclerosis and vascular biology.
Ylä-Herttuala S; Bentzon JF; Daemen M; Falk E; Garcia-Garcia HM; Herrmann J; Hoefer I; Jukema JW; Krams R; Kwak BR; Marx N; Naruszewicz M; Newby A; Pasterkamp G; Serruys PW; Waltenberger J; Weber C; Tokgözoglu L
Thromb Haemost; 2011 Jul; 106(1):1-19. PubMed ID: 21670845
[TBL] [Abstract][Full Text] [Related]
6. Pleiotropic effects of statins: stabilization of the vulnerable atherosclerotic plaque?
Akdim F; van Leuven SI; Kastelein JJ; Stroes ES
Curr Pharm Des; 2007; 13(10):1003-12. PubMed ID: 17430164
[TBL] [Abstract][Full Text] [Related]
7. Changes in coronary plaque morphology in patients with acute coronary syndrome versus stable angina pectoris after initiation of statin therapy.
Gin AL; Vergallo R; Minami Y; Ong DS; Hou J; Jia H; Soeda T; Hu S; Zhang S; Lee H; Yu B; Jang IK
Coron Artery Dis; 2016 Dec; 27(8):629-635. PubMed ID: 27468140
[TBL] [Abstract][Full Text] [Related]
8. Inflammation in atherosclerosis: transition from theory to practice.
Libby P; Okamoto Y; Rocha VZ; Folco E
Circ J; 2010 Feb; 74(2):213-20. PubMed ID: 20065609
[TBL] [Abstract][Full Text] [Related]
9. Serum biomarkers and source of inflammation in acute coronary syndromes and percutaneous coronary interventions.
Centurión OA
Cardiovasc Revasc Med; 2016 Mar; 17(2):119-28. PubMed ID: 26905055
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory strategies for plaque stabilization after acute coronary syndromes.
Baruch A; van Bruggen N; Kim JB; Lehrer-Graiwer JE
Curr Atheroscler Rep; 2013 Jun; 15(6):327. PubMed ID: 23636864
[TBL] [Abstract][Full Text] [Related]
11. Statins induce the accumulation of regulatory T cells in atherosclerotic plaque.
Meng X; Zhang K; Li J; Dong M; Yang J; An G; Qin W; Gao F; Zhang C; Zhang Y
Mol Med; 2012 May; 18(1):598-605. PubMed ID: 22331026
[TBL] [Abstract][Full Text] [Related]
12. Update on the efficacy of statin treatment in acute coronary syndromes.
Rosa GM; Carbone F; Parodi A; Massimelli EA; Brunelli C; Mach F; Vuilleumier N; Montecucco F
Eur J Clin Invest; 2014 May; 44(5):501-15. PubMed ID: 24601937
[TBL] [Abstract][Full Text] [Related]
13. Effect of moderate-intensity statin therapy on plaque inflammation in patients with acute coronary syndrome: A prospective interventional study evaluated by 18F-FDG PET/CT of the carotid artery.
Kim CJ; Han EJ; Chu EH; Hwang BH; Kim JJ; Seung KB; Kim SH; O JH; Chang K
Cardiol J; 2020; 27(6):762-771. PubMed ID: 30009378
[TBL] [Abstract][Full Text] [Related]
14. Reverse vessel remodeling but not coronary plaque regression could predict future cardiovascular events in ACS patients with intensive statin therapy--the extended JAPAN-ACS study.
Miyauchi K; Daida H; Morimoto T; Hiro T; Kimura T; Nakagawa Y; Yamagishi M; Ozaki Y; Kadota K; Kimura K; Hirayama A; Kimura K; Hasegawa Y; Uchiyama S; Matsuzaki M;
Circ J; 2012; 76(4):825-32. PubMed ID: 22451449
[TBL] [Abstract][Full Text] [Related]
15. Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.
Bertrand MJ; Tardif JC
Expert Opin Emerg Drugs; 2017 Mar; 22(1):1-26. PubMed ID: 27927063
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effects of anti-platelet treatment in atherosclerosis.
Arazi HC; Badimon JJ
Curr Pharm Des; 2012; 18(28):4311-25. PubMed ID: 22236116
[TBL] [Abstract][Full Text] [Related]
17. [Anti-platelet therapy in patients with acute coronary syndromes].
Kopaleishvili LA; Dzhashi IM
Georgian Med News; 2014 Nov; (236):105-10. PubMed ID: 25541837
[TBL] [Abstract][Full Text] [Related]
18. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.
Chapman MJ
Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923
[TBL] [Abstract][Full Text] [Related]
19. Targeting the unstable plaque in acute coronary syndromes.
Thompson PL; Nidorf SM; Eikelboom J
Clin Ther; 2013 Aug; 35(8):1099-107. PubMed ID: 23973042
[TBL] [Abstract][Full Text] [Related]
20. Pro-inflammatory Cytokines in Acute Coronary Syndromes.
Mourouzis K; Oikonomou E; Siasos G; Tsalamadris S; Vogiatzi G; Antonopoulos A; Fountoulakis P; Goliopoulou A; Papaioannou S; Tousoulis D
Curr Pharm Des; 2020; 26(36):4624-4647. PubMed ID: 32282296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
